Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rubicon OrganicsROMJF 50 Price-to-Tangible-Book is 1.00 as of Aug. 27, 2026. GuruFocus rates ROMJF with a GF Score™ of 50/100 and a GF Value™ of $0.38 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 837 Drug Manufacturers companies, Rubicon Organics ranks better than 80.76% on this metric.
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Rubicon Organics Price-to-Tangible-Book Related Terms
Rubicon Organics Price-to-Tangible-Book Historical Data
* Premium members only.
The historical data trend for Rubicon Organics's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Rubicon Organics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rubicon Organics Price-to-Tangible-Book vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Rubicon Organics's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Rubicon Organics's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Rubicon Organics (ROMJF) has a Price-to-Tangible-Book of 1.00 as of Aug. 27, 2026. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Rubicon Organics and its competitors. According to the industry distribution chart, Rubicon Organics ranks #161 out of 837 companies in the Drug Manufacturers industry, placing it in the top 19.2%.
Is Rubicon Organics' Price-to-Tangible-Book too high?
Rubicon Organics' current Price-to-Tangible-Book is 1.00. The Drug Manufacturers industry median Price-to-Tangible-Book is 2.30. Rubicon Organics' value of 1.00 is 56.5% below this industry median. Based on the distribution chart, Rubicon Organics ranks #161 out of 837 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Rubicon Organics has a GF Score™ of 50/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Rubicon Organics' Price-to-Tangible-Book compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Rubicon Organics ranks #161 out of 837 companies for Price-to-Tangible-Book. This places Rubicon Organics in the top 19% of its industry — outperforming the majority of peers. The industry median Price-to-Tangible-Book is 2.30. Rubicon Organics' value of 1.00 is 56.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Price-to-Tangible-Book for a Drug Manufacturers company?
The median Price-to-Tangible-Book among Drug Manufacturers companies is 2.30, based on 837 companies in the industry. Companies in the top quartile (top 25%) have a Price-to-Tangible-Book significantly above this median, while those in the bottom quartile fall well below. However, Price-to-Tangible-Book should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rubicon Organics's current Price-to-Tangible-Book of 1.00 is 56.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Price-to-Tangible-Book mean?
A high Price-to-Tangible-Book can signal that a stock is expensive relative to its fundamentals. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Rubicon Organics and its competitors. For the Drug Manufacturers industry, the median Price-to-Tangible-Book is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rubicon Organics's current Price-to-Tangible-Book is 1.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rubicon Organics stock overvalued right now?
Based on GuruFocus' analysis, Rubicon Organics (ROMJF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.38, compared to a current price of $0.42 — trading 10.8% above its estimated fair value. The current Price-to-Tangible-Book is 1.00 and 56.5% below the Drug Manufacturers industry median of 2.30. Rubicon Organics' overall GF Score™ is 50/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Price-to-Tangible-Book calculated?
Price-to-Tangible-Book is calculated from a company's financial statements. For Rubicon Organics (ROMJF), the current Price-to-Tangible-Book is 1.00 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rubicon Organics (ROMJF) Overvalued in 2026?
Based on GuruFocus' analysis, Rubicon Organics stock appears to be overvalued.
The current stock price of $0.42 is trading 10.8% above its estimated GF Value™ of $0.38.
GuruFocus considers Rubicon Organics to be Modestly Overvalued.
Key valuation signals for ROMJF:
Price-to-Tangible-Book: 1.00
GF Value™: $0.38 vs. price of $0.42 (10.8% above fair value)
Industry Position: 56.5% below the Drug Manufacturers median (#161 of 837)
No single metric tells the full story. See the ROMJF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rubicon Organics Inc is engaged in the production and sale of cannabis in Canada. The company produces and processes organic cannabis at its wholly owned, federally licensed 125,000 square foot facility in Delta, British Columbia which it sells under its wholly owned brands and certain wholesale channels. Its brands include Simply Bare, 1964 Supply Co, Wildflower, and Homestead Cannabis Supply. It operates in a single reportable segment, being the production and sale of cannabis in Canada.
50GF Score
Get the complete analysis for ROMJF
Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROMJF has been successfully added to your 
